Jayant Aphale - Net Worth and Insider Trading
Jayant Aphale Net Worth
The estimated net worth of Jayant Aphale is at least $1 Million dollars as of 2024-09-20. Jayant Aphale is the VP, Technical Operations of Sarepta Therapeutics Inc and owns about 11,490 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $1 Million. Details can be seen in Jayant Aphale's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jayant Aphale has not made any transactions after 2016-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jayant Aphale
Jayant Aphale Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jayant Aphale owns 2 companies in total, including Gritstone Bio Inc (GRTS) , and Sarepta Therapeutics Inc (SRPT) .
Click here to see the complete history of Jayant Aphale’s form 4 insider trades.
Insider Ownership Summary of Jayant Aphale
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRTS | Gritstone Bio Inc | 2018-09-27 | See Remarks |
| SRPT | Sarepta Therapeutics Inc | 2016-09-19 | SVP Technical Operations |
Jayant Aphale Latest Holdings Summary
Jayant Aphale currently owns a total of 1 stock. Jayant Aphale owns 11,490 shares of Sarepta Therapeutics Inc (SRPT) as of September 19, 2016, with a value of $1 Million.
Latest Holdings of Jayant Aphale
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2016-09-19 | 11,490 | 127.10 | 1,460,379 |
Holding Weightings of Jayant Aphale
Jayant Aphale Form 4 Trading Tracker
According to the SEC Form 4 filings, Jayant Aphale has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the sale of 35,000 shares on September 19, 2016, which brought Jayant Aphale around $2 Million.
Insider Trading History of Jayant Aphale
- 1
Jayant Aphale Trading Performance
Jayant Aphale Ownership Network
Jayant Aphale Owned Company Details
What does Gritstone Bio Inc do?
Who are the key executives at Gritstone Bio Inc?
Jayant Aphale is the See Remarks of Gritstone Bio Inc. Other key executives at Gritstone Bio Inc include director & President and CEO Andrew R Allen , See Remarks Matthew Hawryluk , and See Remarks Karin Jooss .
Gritstone Bio Inc (GRTS) Insider Trades Summary
Over the past 18 months, Jayant Aphale made no insider transaction in Gritstone Bio Inc (GRTS). Other recent insider transactions involving Gritstone Bio Inc (GRTS) include a net sale of 1,749 shares made by Vassiliki Economides , a net sale of 24,263 shares made by Andrew R Allen , and a net sale of 13,749 shares made by Erin Jones .
In summary, during the past 3 months, insiders sold 0 shares of Gritstone Bio Inc (GRTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 74,769 shares of Gritstone Bio Inc (GRTS) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 62,769 shares.
Gritstone Bio Inc (GRTS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gritstone Bio Inc Insider Transactions
Jayant Aphale Mailing Address
Above is the net worth, insider trading, and ownership report for Jayant Aphale. You might contact Jayant Aphale via mailing address: 215 First Street, Suite 7, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
